Drug Discovery | Biomarkers in Drug Development: Protein Fingerprint | Nordic Bioscience

This video explains how Nordic Bioscience's protein biomarkers can benefit drug discovery and drug development. A simple blood sample can be quantified by the Protein Fingerprint Technology and be used as a sophisticated biomarker tool for tailoring treatment solutions, predicting and monitoring disease progression and treatment response.
For more information, please visit our website: www.nordicbioscience.com
Or contact us: www.nordicbioscience.com/contact
***
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research. With more than 550 peer-reviewed publications, our science-driven approach has been the evolving force behind our decades of success.
Through our Protein Fingerprint technology, we identify fragments of the ECM that are released from affected tissues and develop blood-based biomarker assays to quantify disease activity with the aim of precision medicine.
By quantifying tissue remodeling, our biomarkers provide true prognostic and predictive value, as we can select the patients who are most likely to respond to a given treatment and thereby function as surrogate biomarkers for clinical trials. Our biomarker assays not only enable faster drug development but also improve disease outcomes for chronically ill patients by predicting treatment response.
Nordic Bioscience is headquartered in Herlev, Denmark, with a high-quality standard laboratory, running clinical trials under Good Clinical Laboratory Practice (GCLP) with accreditation by the College of American Pathologists (CAP) and ISO9001 certificate. Everything in our laboratory supports compliance to FDA 21 CFR Part 11. We employ more than 180 people who are dedicated to improving patient management for a broad range of therapeutic areas including Hepatology, Rheumatology, Dermatology, Oncology, Gastroenterology, Respiratory, Neurodegenerative and Cardiovascular diseases.
Follow us on our other social media channels to stay informed on the latest news of cutting-edge biomarker research!
LinkedIn: / nordicbioscience
Twitter: / nordic_bio
#nordicbioscience #lifescience #drugdiscovery #drugdevelopment #extracellularmatrix #biomarkers #proteinfingerprint #medicalanimation #ecm